IP Library Granted Patent US 12,179,014
Granted Patent B2
US 12,179,014 · App. 16/525,060 · Granted Dec 31, 2024

Transvenous phrenic nerve stimulation system

Inventors: Randy W. Westlund (River Falls, WI); Mark Gelfand (New York, NY)
Assignee: ZOLL RESPICARDIA, INC.
A61N1/0558A61N1/05A61N1/0551A61N1/3605A61N1/3611A61N1/3601A61N1/3684
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,179,014
App. No.
16/525,060
Granted
Dec 31, 2024
Kind
B2
Abstract

A lead system and method of use for treating breathing disorders by the transvenous stimulation of the phrenic nerve.

Claims (18)

1. An electrical stimulation lead for delivering energy to a nerve lying close to a vein of a patient comprising:

an elongate lead body having a proximal end and a distal end;

a plurality of electrodes to stimulate a phrenic nerve of the patient, the plurality of electrodes being located along the elongate lead body near the distal end;

a proximal connector included in the proximal end and having an electrical connection;

a plurality of conductors located in an interior of the elongate lead body connecting each electrode of the plurality of electrodes to the electrical connection; and

a plurality of bend curves, all of the plurality of bend curves being free of any of the plurality of electrodes and having arcuate shapes to cause a bias force to be exerted by the electrical stimulation lead to maintain the distal end substantially immobile in a pericardiophrenic vein of the patient, wherein at least one bend curve of the plurality of bend curves is configured to apply a bias force to a vessel wall of the pericardiophrenic vein, wherein the at least one bend curve is shaped to deflect around a radius such that the bias force stabilizes the plurality of electrodes in the pericardiophrenic vein.

2. The electrical stimulation lead of claim 1 , wherein a first section of the elongate lead body lies in a first plane and a second section of the elongate lead body lies in a second plane which intersects the first plane.

3. The electrical stimulation lead of claim 2 , wherein the second plane intersects the first plane at an angle of about 15 degrees.

4. The electrical stimulation lead of claim 2 , wherein the second section of the elongate lead body terminates in a tapered distal tip segment.

5. The electrical stimulation lead of claim 1 , wherein the distal end of the elongate lead body terminates in a tapered distal tip segment.

6. The electrical stimulation lead of claim 5 , wherein at least one of the plurality of electrodes is disposed proximal of the tapered distal tip segment.

7. The electrical stimulation lead of claim 1 , wherein the plurality of electrodes includes only two electrodes.

8. The electrical stimulation lead of claim 1 , wherein the elongate lead body includes a stylet lumen extending partially through the elongate lead body.

9. The electrical stimulation lead of claim 1 , wherein the elongate lead body includes a drug-eluting coating.

10. The electrical stimulation lead of claim 1 , wherein the elongate lead body includes a guide wire lumen.

11. The electrical stimulation lead of claim 10 , wherein the guide wire lumen extends entirely through the elongate lead body.

12. The electrical stimulation lead of claim 1 , wherein the elongate lead body is configured to accept insertion of a guide wire for implantation of the elongate lead body in the pericardiophrenic vein of the patient.

13. The electrical stimulation lead of claim 12 , wherein the guide wire is configured to straighten the elongate lead body.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 056267 FRAME: 0334. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded May 25, 2021
From: RESPICARDIA, INC.
To: ZOLL RESPICARDIA, INC.
Reel/Frame 056366/0506 →
CHANGE OF NAME Recorded May 17, 2021
From: RESPICARDIA, INC.
To: ZOLL RESPICARDIA, INC.
Reel/Frame 056267/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2021
From: WESTLUND, RANDY W.; GELFAND, MARK
To: RESPICARDIA, INC.
Reel/Frame 055314/0400 →
Continuity (8)
Continuation 12150654 · Apr 30, 2008
Continuation In Part 11601150 · Nov 17, 2006
Provisional Application 60926910 · Apr 30, 2007
Provisional Application 60743326 · Feb 21, 2006
Provisional Application 60743062 · Dec 21, 2005
Provisional Application 60737808 · Nov 18, 2005
Related Publication 20190351229A1 · Nov 21, 2019
Related Publication 20220212005A9 · Jul 7, 2022